3 Stocks I Saw on T...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$39.93 0.26 | 0.66%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 39.67 |
| 52 Week High | 44.95 |
| 52 Week Low | 28.82 |
| Avg. Daily Vol. (Mil) | 0.71 |
| Beta (3 year) | 0.51 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,512.59 |
| Shares Out (Mil) | 63.34 |
| Float (Mil) | 54.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.40 |
| Current Ratio | 5.90 |
| LT Debt/ Equity | 0.54 |
| Total Debt / Equity | 0.54 |
| Valuation Ratios | |
| Price Earnings | 72.10 |
| Price/Sales | 3.13 |
| Price/Book | 2.94 |
| Price/Cash Flow | 28.50 |
| Per Share Data | |
| Earnings | 0.55 |
| Sales | 12.68 |
| Book Value | 13.50 |
| Cash Flow | 1.39 |
| Business Summary | |
|---|---|
| Cubist Pharmaceuticals, Inc is focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. | |
| General Information | |
| 65 Hayden Avenue
Lexington, MA 02421 |
|
| www.cubist.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 669 | |
| CEO: Michael W. Bonney | |
| Short Interest | |
| Current Month (Mil) | 10.42 |
| Previous Month (Mil) | 10.67 |
| Short Interest Ratio (Days) | 12.70 |
| Management Effectiveness | |
| Return on Equity | 5.10 |
| Return on Assets | 2.30 |
| Return on Investments | 3.30 |
| Profitability | |
| Gross Margin | 81.90 |
| EBIT Margin | 18.80 |
| Profit Margin | 5.40 |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ProJoel Greenblatt - Gotham Ca...
- ContributorEarnings Short Squeeze Play...
Latest CBST Headlines from TheStreet
- Upgrades Roundup: TXT, CBST, BK, MCP, AVP, LFL, SHO, BPI 04.23.12 | 06:04 am
- Cubist Pharmaceuticals Inc. Stock Upgraded (CBST) 04.20.12 | 05:04 am
- 5 Stocks Poised to Pop on Earnings 04.18.12 | 07:04 am
- Cubist Stock Hits New 52-Week High (CBST) 03.26.12 | 11:03 am
- Cubist Stock Hits New 52-Week High (CBST) 03.09.12 | 10:03 am
- Cubist Reaches New 52-Week High (CBST) 02.22.12 | 03:02 pm
- Cubist Stock Hits New 52-Week High (CBST) 02.03.12 | 10:02 am
- TheStreet Ratings Top 10 Rating Changes 01.23.12 | 12:01 pm
- Cubist Pharmaceuticals Inc. Stock Downgraded (CBST) 01.23.12 | 05:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.18.12 | 03:01 pm
Press Releases for CBST
- Cubist Pharmaceuticals Marks 20th Anniversary By Making Its Largest-Ever Commitment To STEM Programs - Business Wire 05.16.12 | 09:05 am
- Cubist Pharmaceuticals To Present At May Investor Conference - Business Wire 05.07.12 | 10:05 am
- Cubist Announces Positive Results From ENTEREG® Phase 4 Study In Patients Undergoing Radical Cystectomy - Business Wire 04.17.12 | 05:04 pm
- Cubist Pharmaceuticals To Announce Q112 Financial Results On Wednesday, April 18th, 2012 - Business Wire 04.02.12 | 10:04 am
- Senator Scott Brown And Cubist Pharmaceutical President And CEO Michael Bonney (right) And Steven Gilman, Executive Vice President, Research & Development And Chief Scientific Officer. - Business Wire 03.16.12 | 12:03 pm
- Cubist Pharmaceuticals Appoints Jane Henney To Board Of Directors - Business Wire 03.09.12 | 08:03 am
- Cubist Pharmaceuticals To Present At February/March Investor Conferences - Business Wire 02.20.12 | 11:02 am
- Cubist Pharmaceuticals Appoints Alison Lawton To Board Of Directors - Business Wire 02.16.12 | 08:02 am
- Cubist Receives CUBICIN Paragraph IV Notice Letter - Business Wire 02.09.12 | 07:02 am
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter And Full Year Financial Results - Business Wire 01.19.12 | 04:01 pm
Partner Headlines for CBST
- After Hours Most Active for Jun 1, 2012 : BAC, QQQ, MSFT, JPM, KITD, SWK, WFC, WMB, MET, STX, CBST, INTC - NASDAQ 06.01.12 | 08:06 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medical Stocks Forming Bases Amid Market Sell-Off - Investor's Business Daily 05.18.12 | 06:05 pm
- Big Pharma Abandons Antibiotics: An Opening For Small Biotech - Seeking Alpha 05.13.12 | 09:05 am
- 2 Low-Growth Pharma Behemoths: Merck, J&J - Seeking Alpha 05.01.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Alnylam Delivers In-Line Numbers - Analyst Blog - Zacks 02.13.12 | 10:02 am
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Cubist's Preliminary Sales Impress - Analyst Blog - Zacks 01.11.12 | 10:01 am
- Alnylam States Preclinical Data - Analyst Blog - Zacks 12.30.11 | 04:12 pm
